Wabash National (NYSE:WNC – Free Report) had its price objective lowered by DA Davidson from $9.50 to $9.00 in a research report released on Monday morning,Benzinga reports. DA Davidson currently has a neutral rating on the stock. DA Davidson also issued estimates for Wabash National’s FY2026 earnings at $0.61 EPS.
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Wabash National in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus target price of $9.00.
Check Out Our Latest Report on Wabash National
Wabash National Stock Down 1.9%
Wabash National (NYSE:WNC – Get Free Report) last released its quarterly earnings data on Wednesday, December 1st. The company reported $0.22 earnings per share for the quarter. Wabash National had a negative net margin of 6.38% and a negative return on equity of 7.91%. The business had revenue of $482.57 million for the quarter. Wabash National has set its Q4 2021 guidance at $0.100-$0.150 EPS. As a group, sell-side analysts predict that Wabash National will post 0.94 EPS for the current year.
Wabash National Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 2nd will be given a dividend of $0.08 per share. The ex-dividend date is Thursday, October 2nd. This represents a $0.32 annualized dividend and a dividend yield of 3.7%. Wabash National’s dividend payout ratio (DPR) is -13.22%.
Hedge Funds Weigh In On Wabash National
Several large investors have recently made changes to their positions in WNC. Allworth Financial LP boosted its position in shares of Wabash National by 268.8% during the 1st quarter. Allworth Financial LP now owns 3,220 shares of the company’s stock valued at $34,000 after purchasing an additional 2,347 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Wabash National by 55.9% during the 2nd quarter. PNC Financial Services Group Inc. now owns 3,710 shares of the company’s stock valued at $39,000 after purchasing an additional 1,331 shares in the last quarter. CWM LLC boosted its position in shares of Wabash National by 1,520.7% during the 1st quarter. CWM LLC now owns 5,235 shares of the company’s stock valued at $58,000 after purchasing an additional 4,912 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Wabash National by 982.1% during the 1st quarter. GAMMA Investing LLC now owns 7,683 shares of the company’s stock valued at $85,000 after purchasing an additional 6,973 shares in the last quarter. Finally, Signaturefd LLC boosted its position in shares of Wabash National by 1,517.3% during the 1st quarter. Signaturefd LLC now owns 8,976 shares of the company’s stock valued at $99,000 after purchasing an additional 8,421 shares in the last quarter. Institutional investors own 97.05% of the company’s stock.
Wabash National Company Profile
Wabash National Corporation provides connected solutions for the transportation, logistics, and distribution industries primarily in the United States. The company operates through two segments, Transportation Solutions and Parts & Services. The Transportation Solutions segment designs and manufactures transportation-related equipment and products dry and refrigerated van trailers, platform trailers, tank trailers, and truck-mounted tanks; truck bodies for dry-freight transportation; cargo and cargo XL bodies for commercial applications; refrigerated truck bodies; platform truck bodies; and used trailers, as well as laminated hardwood oak flooring products.
See Also
- Five stocks we like better than Wabash National
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to Invest in Insurance Companies: A Guide
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Differences Between Momentum Investing and Long Term Investing
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Wabash National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wabash National and related companies with MarketBeat.com's FREE daily email newsletter.